Compounds > lg 100268

lg 100268 and cyclin d1

lg 100268 has been researched along with cyclin d1 in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Glozak, MA; Li, Y; Rogers, MB; Smith, SM1
Breyer, MD; Breyer, RM; Davis, L; Guan, YF; Zhang, YH1
Bissonnette, RP; Brown, PH; Hill, J; Hilsenbeck, SG; Kim, HT; Lamph, WW; Li, Y; Shen, Q; Xu, X; Zhang, Y1

Other Studies

3 other study(ies) available for lg 100268 and cyclin d1

ArticleYear
The expression and activity of D-type cyclins in F9 embryonal carcinoma cells: modulation of growth by RXR-selective retinoids.
    Experimental cell research, 1999, Dec-15, Volume: 253, Issue:2

    Topics: Alitretinoin; Animals; Antineoplastic Agents; Benzoates; Biomarkers; Carcinoma, Embryonal; Cell Adhesion; Cell Differentiation; Cell Division; Cyclin D1; Cyclin D2; Cyclin D3; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinases; Cyclins; Endoderm; Gene Expression Regulation, Neoplastic; Nicotinic Acids; Proto-Oncogene Proteins; Receptors, Retinoic Acid; Retinoid X Receptors; RNA, Messenger; Stem Cells; Tetrahydronaphthalenes; Transcription Factors; Transcription, Genetic; Tretinoin; Tumor Cells, Cultured

1999
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death.
    Neoplasia (New York, N.Y.), 1999, Volume: 1, Issue:4

    Topics: Alitretinoin; Antineoplastic Agents; Apoptosis; Carcinoma, Transitional Cell; Carrier Proteins; Cell Death; Chromans; Cyclin D1; Cyclin-Dependent Kinase Inhibitor p16; Cyclin-Dependent Kinase Inhibitor p21; Cyclins; DNA; DNA, Complementary; Dose-Response Relationship, Drug; Fatty Acid-Binding Protein 7; Fatty Acid-Binding Proteins; G1 Phase; Humans; Immunoblotting; In Situ Hybridization; Ligands; Luciferases; Myelin P2 Protein; Neoplasm Proteins; Nicotinic Acids; Receptors, Cytoplasmic and Nuclear; Receptors, Retinoic Acid; Retinoid X Receptors; Ribonucleases; Tetrahydronaphthalenes; Thiazoles; Thiazolidinediones; Transcription Factors; Transcriptional Activation; Transfection; Tretinoin; Troglitazone; Tumor Cells, Cultured; Tumor Suppressor Proteins; Urinary Bladder Neoplasms

1999
The Rexinoid LG100268 prevents the development of preinvasive and invasive estrogen receptor negative tumors in MMTV-erbB2 mice.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2007, Oct-15, Volume: 13, Issue:20

    Topics: Animals; Anticarcinogenic Agents; Cell Line, Tumor; Cyclin D1; Female; Humans; Immunohistochemistry; Ki-67 Antigen; Mammary Tumor Virus, Mouse; Mice; Mice, Transgenic; Neoplasm Invasiveness; Neoplasm Transplantation; Nicotinic Acids; Receptor, ErbB-2; Receptors, Estrogen; Tetrahydronaphthalenes; Time Factors; Transgenes

2007